[Collateral effects of therapy with L-dopa in Parkinson's disease].
D001145:Arrhythmias, Cardiac / Q000139:chemically induced; D002395:Catecholamines / Q000378:metabolism; D004295:Dihydroxyphenylalanine / Q000009:adverse effects*; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006801:Humans; D007024:Hypotension, Orthostatic / Q000139:chemically induced; D009069:Movement Disorders / Q000139:chemically induced; D010300:Parkinson Disease / Q000188:drug therapy*
D002395:Catecholamines; D004295:Dihydroxyphenylalanine
Effetti collaterali della terapia con L-dopa nel morbo di Parkinson.